SDEV Company Profile and Key Details

Average 10-day trading volume of 701.30 thousand shares is significantly above the 3-month average of 309.70 thousand, indicating heightened recent market interest.

Stablecoin Development Corp. earnings surprise history is a mixed track record. The quarter that ended May 15, 2026, missed forecasts by -110.0%.

Our AI price prediction model suggests that Stablecoin Development Corp. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.92%, with price expected at $1.06 by July 15, 2026, within a range of $0.99 to $1.13 3-Month Outlook: Projected fall of -99.04%, reaching $0.01 by September 29, 2026, with a range of $0.00 to $0.02. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by July 01, 2027, within a range of $0.00 to $0.01.

Valuation shows Stablecoin Development Corp. trading at a premium to the broader market with a P/E of 0.06. Our AI forecast model points to short-term strength (1.92% over two weeks), a medium-term fall (-99.04% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.

Stablecoin Development Corp. last paid a dividend of 4 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $1.23. This means the shares are trading above this model’s fair value.

Stablecoin Development Corp. (AMEX:SDEV) closed at $1.43 USD, gaining $0.39 (37.70%) from the previous close of $1.04. The stock is currently mid-range between its 52-week high and low $1.00 and $2.13. With a market capitalization of about $38.83 million, Stablecoin Development Corp. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.08). Headquartered in Emeryville, CA, Stablecoin Development Corp. operates in the Healthcare sector and the Medical - Pharmaceuticals industry. Led by CEO Michael Kazley, the company employs approximately 4 people and listed since April 06, 2026. Stablecoin Development Corp. specializes in manufacturing and distributing eye and skin health solutions that have undergone rigorous scientific development and proven efficacy in clinical settings.

Stablecoin Development Corp. trades at a P/E ratio of 0.06, slightly below the S&P 500 average, with a price-to-sales ratio of 11.45 and a price-to-book ratio of 0.19 suggesting the stock is closer to book value. The P/FCF stands at -3.17, also above market averages.